FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to regulation 30 and 46 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, a conference call is scheduled with Investors on Friday March 27, 2020 at 12:00 noon. The Conference call invite is attached. This is for your information and records please. FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Credit Rating
In compliance of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, this is to inform you that at the request of the Escorts Heart Institute & Research Centre Limited (Company's Subsidiary), ICRA Limited has withdrawn [ICRA] BBB+& (pronounced ICRA Triple B Plus; on watch with developing implications) and short term rating of [ICRA]A2& (pronounced ICRA A two; on watch with developing implications) assigned to Rs 35.0 crore. The relevant paper received from ICRA Limited is attached herewith. This is for your information and records please. Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Credit Rating
With reference to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, it is hereby informed that today i.e. March 17, 2020, CRISIL Limited ('CRISIL') has assigned following credit rating of long term debts and short term debts of Fortis Healthcare Limited ('the Company') and subsidiaries of the Company viz. 1. International Hospital Limited; and 2. Fortis Hospitals Limited 1. Long Term Loan- 'CRISIL A (Placed on Rating Watch with Developing Implications)'. 2. Short Term Loan- 'CRISIL A1 (Continuous on Rating Watch with Developing Implications)'. This is for your information and records please. FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Credit Rating
With reference to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, it is hereby informed that Yesterday i.e. March 11, 2020, CRISIL Limited ('CRISIL') has assigned credit rating of short term debts of Fortis Healthcare Limited ('the Company') and subsidiaries of the Company viz. 1. International Hospital Limited; and 2. Fortis Hospitals Limited as 'CRISIL A1- Rating Watch with Developing Implications'. This is for your information and records please. FORTIS HEALTHCARE LTD. - 532843 - Intimation Under Regulation 30
This is in continuation of our letter ref. no. FHL/SEC/2018-19 dated December 17, 2018 and letter dated November 18, 2019 in the matter titled 'Vinay Prakash Singh v. Sameer Gehlaut & Ors.' pending before Hon'ble Supreme Court of India ('Court'). Kindly be informed that Northern TK Venture Pte Ltd. (NTK) (promoter of the Company) through its legal counsel has today filed applications. Earnings Call Transcript - Fortis Healthcare
Full Earnings Transcript: Conference Call between Management and Analysts Apollo to Fortis: Hospital stocks among safest bets in the healthcare space
The largest listed player in this space, Apollo Hospitals, has been a standout performer with growth being led by both hospitals and pharmacy businesses. FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find enclosed Investor Presentation for the financial results of the Company for the quarter and period ended on December 31, 2019. This is for your information and records please.
Fortis Q3 net loss narrows to Rs 69.32 cr
The third quarter of 2019-20 continues to witness earnings growth with margin expansion in the hospitals business. Fortis Healthcare Ltd - 532843 - Outcome Of The Board Meeting
Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e. February 14, 2020, inter-alia, considered and approved standalone and consolidated un-audited financial results of the Company for the quarter and period ended on December 31, 2019 along with limited review report thereon; Please find enclosed standalone and consolidated un-audited financial results along with limited review report given by the Statutory Auditor of the Company for quarter and period ended on December 31, 2019 and statement of deviation or variation for proceeds of Preferential issue and a copy of the press release being issued in this regard. The Board Meeting commenced at 1330 Hours and concluded at 2015 Hours. This is for your information and records please.